Volume 28, Issue 130 (September & October 2020)                   J Adv Med Biomed Res 2020, 28(130): 237-246 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Motatabzadeh S M, Abtahi Froushani S M. Effects of Adding Dexpanthenol to Prednisolone in an Experimental Model of Inflammatory Bowel Disease. J Adv Med Biomed Res 2020; 28 (130) :237-246
URL: http://journal.zums.ac.ir/article-1-6044-en.html
Effects of Adding Dexpanthenol to Prednisolone in an Experimental Model of Inflammatory Bowel Disease
Seyedeh Mehrnaz Motatabzadeh1 , Seyed Meysam Abtahi Froushani * 2
1- Department of Microbiology, Faculty of veterinary Medicine, Urmia University, Urmia, Iran
2- Department of Microbiology, Faculty of veterinary Medicine, Urmia University, Urmia, Iran , meysamabtahi@hotmail.com
Abstract:   (142800 Views)

Background & Objective: Inflammatory bowel diseases (IBDs) represent serious chronic auto-inflammatory conditions, affecting the alimentary tract. The beneficial effect of dexpanthenol has been observed on some inflammatory conditions. Here, the therapeutic potential of combined dexpanthenol and prednisolone in alleviating the symptoms of the animal model of IBD was investigated.
Materials & Methods: Luminal instillation of 4% acetic acid (2 ml for each rat) was used to induce IBD. Rats in the treatment groups received dexpanthenol (500 mg/kg), prednisolone (2 mg/kg), or a combination of both (half doses of each drug) by oral gavage for 11 consecutive days. 
Results: Dexpanthenol could regress the clinical scores of the IBD model more than prednisolone. More importantly, combination therapy with half doses of dexpanthenol and prednisolone caused more considerable improvement in the disease activity index (DAI) compared to IBD rats received monotherapy. Both monotherapies promoted a remarkable decrease in the messenger RNA (mRNA) expression of NF-κBp65, as well as the levels of interleukin 6 (IL-6) and TNF-α activity in the inflamed colon. Dexpanthenol could regress the intensity of malondialdehyde (MDA), myeloperoxidase (MPO), and nitric oxide (NO) in the inflamed colon more than prednisolone. More importantly, our results demonstrated that combination therapy resulted in a much more prominent decrease in the level of TNF-α and NF-κBp65, as well as the level of superoxide dismutase (SOD) and total gut protein content, than monotherapy. Conversely, combination therapy resulted in a much more pronounced decrease in NO and MDA levels than those recorded in IBD rats received individual treatment. Finally, the mRNA level of IκBα did not show any remarkable discrepancy between the experimental groups.
Conclusion: The combination of dexpanthenol and prednisolone could be used as a promising strategy to alleviate the signs of IBD.

Keywords: Dexpanthenol, Prednisolone, Inflammatory bowel diseases, Combination therapy
Full-Text [PDF 618 kb]   (154983 Downloads) |   |   Full-Text (HTML)  (3691 Views)  
Type of Study: Original Article | Subject: Medical Biology
Received: 2020/06/1 | Accepted: 2020/09/16 | Published: 2020/09/21
References
1. Cerquetella M, Spaterna A, Laus F, et al. Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterology. 2010;16(9):1050-6. [DOI:10.3748/wjg.v16.i9.1050]
2. Grosse CSJ, Christophersen CT, Devine A, Lawrance IC. The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases. Expert Rev Gastroenterol Hepatology. 2020;3:1-9. [DOI:10.1080/17474124.2020.1733413]
3. Abtahi Froushani SM, Mashhouri S. The effect of mesenchymal stem cells pulsed with 17 beta-estradiol in an ameliorating rat model of ulcerative colitis. Zahedan J Res Med Sci. 2019;21(4):e83762. [DOI:10.5812/zjrms.83762]
4. Agrawal G, Clancy A, Sharma R, Huynh R, Ramrakha S, Borody T. Targeted combination antibiotic therapy induces remission in treatment-naive crohn's disease: A case series. Microorganisms. 2020;8(3). [DOI:10.3390/microorganisms8030371]
5. Yousefi-Ahmadipour A, Ebrahimi-Barough S, Niknia S,et al. Therapeutic effects of combination of platelet lysate and sulfasalazine administration in TNBS-induced colitis in rat. Biomed Pharmacother. 2020;125:109949. [DOI:10.1016/j.biopha.2020.109949]
6. Li-Mei W, Jie T, Shan-He W, Dong-Mei M, Peng-Jiu Y. Anti-inflammatory and anti-oxidative effects of dexpanthenol on lipopolysaccharide induced acute lung injury in mice. Inflammation. 2016;39(5):1757-63. [DOI:10.1007/s10753-016-0410-7]
7. Soylu Karapinar O, Pinar N, Ozgur T, et al. The protective role of dexpanthenol on the endometrial implants in an experimentally induced at endometriosis model. Reproduc Sci (Thousand Oaks, Calif). 2017;24(2):285-90. [DOI:10.1177/1933719116653682]
8. Gheita AA, Gheita TA, Kenawy SA. The potential role of B5: A stitch in time and switch in cytokine. Phytother Res. 2020;34(2):306-14. [DOI:10.1002/ptr.6537]
9. Karadag A, Ozdemir R, Kurt A, et al. Protective effects of dexpanthenol in an experimental model of necrotizing enterocolitis. J Pediatr Surg. 2015;50(7):1119-24. [DOI:10.1016/j.jpedsurg.2014.10.053]
10. Etensel B, Ozkisacik S, Ozkara E, et al. Dexpanthenol attenuates lipid peroxidation and testicular damage at experimental ischemia and reperfusion injury. Pediatr Surg Int. 2007;23(2):177-81. [DOI:10.1007/s00383-006-1781-x]
11. Baron JM, Glatz M, Proksch E. Optimal support of wound healing: New Insights. Dermatol (Basel, Switzerland). 2020:1-8. [DOI:10.1159/000505291]
12. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Develop Ther. 2013;7:1341-57. [DOI:10.2147/DDDT.S40107]
13. Tahmasebi P, Abtahi froushani SM, Afzale Ahangaran N. Thymol has beneficial effects on the experimental model of ulcerative colitis. Avicenna J Phytomed. 2019;9(6):538-50.
14. Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al-Assaf AH, Parmar MY, Ahmed MM. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol. 2013;19(34):5633-44. [DOI:10.3748/wjg.v19.i34.5633]
15. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497-500. [DOI:10.1093/clinchem/34.3.497]
16. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-69.
17. Al-Rejaie SS, Aleisa AM, Sayed-Ahmed MM, et al. Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male wistar rat. BMC Complement Alternat Med. 2013;13:136. [DOI:10.1186/1472-6882-13-136]
18. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Rad Biol Med. 2007;43(5):645-57. [DOI:10.1016/j.freeradbiomed.2007.04.026]
19. Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest. 2014;43(1):54-68. [DOI:10.3109/08820139.2013.825269]
20. Golbahari S, Abtahi Froushani SM. Synergistic benefits of nicotine and thymol in alleviating experimental rheumatoid arthritis. Life Sci. 2019;239:117037. [DOI:10.1016/j.lfs.2019.117037]
21. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Molec Cell Endocrinol. 2007;275(1-2):71-8. [DOI:10.1016/j.mce.2007.05.019]
22. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91-9. [DOI:10.3748/wjg.v20.i1.91]
23. Abtahi Froushani SM, Mashouri S. The beneficial effects of hypiran in Ameliorating Rat Model of Ulcerative Colitis. Zahedan J Res Med Sci. 2018;20(1):e58919. [DOI:10.5812/zjrms.58919]
24. Bilgic Y, Akbulut S, Aksungur Z, et al. Protective effect of dexpanthenol against cisplatin-induced hepatotoxicity. Experiment Therap Med. 2018;16(5):4049-57. [DOI:10.3892/etm.2018.6683]
25. Wojtczak L, Slyshenkov VS. Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals--the role of glutathione. BioFactors (Oxford, England). 2003;17(1-4):61-73. [DOI:10.1002/biof.5520170107]
26. Owusu G, Obiri DD, Ainooson GK, et al. Acetic acid-induced ulcerative colitis in sprague dawley rats is suppressed by hydroethanolic extract of Cordia vignei Leaves through reduced serum levels of TNF-alpha and IL-6. Int J Chron Dis. 2020;2020:8785497. [DOI:10.1155/2020/8785497]
27. Verstockt B, Ferrante M, Vermeire S, Van Assche G. New treatment options for inflammatory bowel diseases. J Gastroenterol. 2018;53(5):585-90. [DOI:10.1007/s00535-018-1449-z]
28. Gautam MK, Goel S, Ghatule RR, Singh A, Nath G, Goel RK. Curative effect of Terminalia chebula extract on acetic acid-induced experimental colitis: role of antioxidants, free radicals and acute inflammatory marker. Inflammopharmacol. 2013;21(5):377-83. [DOI:10.1007/s10787-012-0147-3]
29. Neurath MF. Cytokines in inflammatory bowel disease. Nature Rev Immunol. 2014;14(5):329-42. [DOI:10.1038/nri3661]
30. Li Z, Zheng J, Zhang N, Li C. Berberine improves airway inflammation and inhibits NF-kappaB signaling pathway in an ovalbumin-induced rat model of asthma. J Asthma. 2016;53(10):999-1005. [DOI:10.1080/02770903.2016.1180530]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb